Association of Renin-Angiotensin System Inhibitors With Severity or Risk of Death in Patients With Hypertension Hospitalized for Coronavirus Disease 2019 (COVID-19) Infection in Wuhan, China

Analysis of data from 1178 patients found the proportion of patients taking ACEI or ARBs (115 overall) did not differ between those with severe and non-severe infections (32.9% vs 30.7%; P=0.65) or between non-survivors and survivors (27.3% vs 33.0%; P=0.34).

Source:

JAMA Cardiology